|
|
|
Ekso Bionics Holdings Inc 
|
10 0.65 (0.07%) |
01-22 16:00 |
Open: |
9.36 |
Pre close: |
9.35 |
Target:
|
12.38
|
High: |
10.27 |
Low: |
9.12 |
Resistance:
|
10.60
12.38 
|
Volume: |
402,026 |
Market Cap: |
83M |
Support:
|
7.23
5.15
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
9.01
 |
MACD |
MACD(12,26):
|
0.96  |
MA(20): |
7.59  |
Signal(12,26,9): |
0.77  |
MA(100): |
5.41  |
Stochastic Oscillator |
%K(14,3):
|
85.91  |
MA(250): |
5.08  |
%D(3): |
79.97  |
Average Volume(K) |
3-Month: |
16139
|
52-Week |
High:
|
10.74 |
10-Days: |
38720 |
Low: |
2.25 |
RSI |
RSI(14):
|
75.20  |
Change(%): |
83.7 |
Financials, Statistics and Valuation |
EPS |
-2.350 |
Return on Equity (ttm) |
-196.6 |
Shares Out. (M) |
8.32 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-36.3 |
Shares Float (M) |
6.81 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.54 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-12.7 |
% Held by Institutions |
18.91 |
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.813 |
Shares Short (K) |
146 |
Book Value (p.s.) |
1.010 |
EBITDA (p.s.) |
-1.450 |
P/E |
-4.26 |
Sales Per Share |
1.244 |
Qtrly Earnings Growth |
1090.30 |
P/BV |
9.90 |
Profit Margin |
-140.80 |
Operating Cash Flow
(M) |
-8.51 |
P/S |
8.04 |
Operating Margin |
-122.73 |
Levered Free Cash Flow
(M) |
-2.78 |
P/CF |
-9.78 |
|
|
|
|
|